Author:
Kohgo Yutaka,Sakamaki Sumio,Kanisawa Yuji,Nojiri Shuichi,Ueno Yoshinori,Itoh Yoshinori,Takahashi Minoru,Sasagawa Yutaka,Hosoi Shinji,Sato Seiji,Niitsu Yoshiro
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology
Reference16 articles.
1. Adler A, Chervenick PA, Whitesilde TL, Lotzova E and Herbermann RB (1988) Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. 1. Feasibility of LAK generation in adult patients with active disease and in remission. Blood 71: 709?716.
2. Alter BJ, Ochoa AC, Gruenberg M, Keyport GM and Bach FH (1987) The growth of cells with LAK activity in an automated tissue culture system (Acusyst P). Prog. Clin. Biol. Res. 244: 301?311.
3. Grimm EA, Mazunider M, Zhang HZ and Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155: 1823?1841.
4. Hinuma S, Naruo O, Shiho O and Tsukamoto K (1986) Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin 2. Immunology 59: 251?259.
5. Itoh K, Tilden AB, Kumagai K and Balch CM (1985) Leu 11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL-2) induced activated killer (AK) cells. J. Immunol. 134: 802?807.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献